E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/6/2022 in the Prospect News Bank Loan Daily.

S&P boosts Red Ventures

S&P said it raised its ratings on Red Ventures HoldCo LP and its first-lien secured debt to BB- from B+.

Red Ventures combined its Healthline and HealthGrades businesses into a 50/50 joint venture with UnitedHealth Group Optum to form Red Ventures Optum Health. Red Ventures received gross proceeds of $2 billion and used $1.3 billion for debt repayment.

“After repaying $1.3 billion in debt using asset sale proceeds, Red Ventures' leverage will be below 3x for the first time since 2016, representing a substantial change in the company's leverage profile. Leverage was 5.8x at the end of 2021 due to debt-financed acquisitions, and acquisition spending has totaled $2.5 billion over the last three years, most of it debt funded,” S&P said in a press release.

The agency added, “We believe Red Ventures' leverage likely would spike in a recession but expect it will remain below our 4x leverage threshold associated with the BB- rating.”

The outlook is stable.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.